Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers

NCT02778789 · clinicaltrials.gov ↗

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab
DRUG: TNF-alpha Inhibitor

Sponsor

University of Erlangen-Nürnberg Medical School